Drug News

Added 15 hours ago Drug news

Tirasemtiv: no improvement found in respiratory function in patients with neurodegenerative disease

Tirasemtiv development ended for amyotrophic lateral sclerosis.

Added 15 hours ago Drug news

Light Adjustable Lens signals breakthrough in post cataract surgery

FDA approves the Light Adjustable Lens and Light Delivery Device for post cataract surgery.

Added 15 hours ago Drug news

New treatment approved to treat ovarian cancer

Zejul, approved by the European Commission, is the first once-daily, oral poly (ADP-ribose) polymerase (PARP)1/2 inhibitor to be approved in Europe that does not require BRCA mutation or other biomarker testing.


Added 1 day ago Drug news

Ardelyx, to discontinue development of RDX 7675 for the treatment of hyperkalemia.

Ardelyx, Inc. provided an update on the development of its cardiorenal pipeline. The company's second registration study for tenapanor for...

Added 1 day ago Drug news

Tirasemtiv fails Phase III study for amyotrophic lateral sclerosis

Cytokinetics Incorporated announced that VITALITY-ALS trial did not meet the primary endpoint.

Added 1 day ago Drug news

Janssen Biotech files sBLA with FDA for Darzalex combination in newly diagnosed multiple myeloma

Janssen Biotech announced that it has submitted a supplemental Biologics License Application (sBLA) to the FDA for Darzalex (daratumumab).

Added 1 day ago Drug news

European Commission approves Zubsolv to treat opioid dependence.- Orexo AB + Mundipharma.

Orexo AB (publ.) announced that the European Medicines Agency (EMA) has granted a Marketing Authorization (MA) for Zubsolv (buprenorphine and...

Added 1 day ago Drug news

FDA approves Juluca reducing the drugs needed to treat HIV

The FDA has approved Juluca (dolutegravir and rilpivirine), from Viiv Healthcare, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1.

Added 2 days ago Drug news

Biosimilar approved by EU for treatment of breast cancer and metastatic gastric cancer

EU approves Ontruzant (trastuzumab biosimilar).

Search all news articles